Rita Aghjayan

Assistant Editor

Rita Aghjayan is a graduate from Pace University in NYC with a BS in Biology and MS in Biochemistry & Molecular Biology. She is the assistant editor for the Clinical Advisor. 

Most Recent Articles by Rita Aghjayan

Beyond <I>BRCA</i>: New Predisposition Genes Linked to Breast, Ovarian Cancers

Beyond BRCA: New Predisposition Genes Linked to Breast, Ovarian Cancers

By

Whole-exome sequencing revealed that PALB2, ATM, CHEK2, and MSH6 genes were significantly associated with an increased risk of breast cancer; MSH6, RAD51C, TP53, and ATM were found to be linked to an increased risk of ovarian cancer.

McCune-Albright Syndrome Linked to Broad Range of Gastrointestinal Pathologies

McCune-Albright Syndrome Linked to Broad Range of Gastrointestinal Pathologies

By

Intraductal papillary mucinous neoplasms and numerous gastrointestinal tumors have been linked to somatic gain-of-function GNAS mutations, which can lead to McCune-Albright syndrome.

Increased Dairy Consumption Linked to Reduced CVD, Mortality Risk in Low-, Middle-Income Countries

Increased Dairy Consumption Linked to Reduced CVD, Mortality Risk in Low-, Middle-Income Countries

By

The consumption of whole-fat dairy products may reduce cardiovascular disease and mortality risk, contrary to current dietary guidelines that advise limited consumption of fat-free or low-fat dairy products.

Short-Course Oral Steroids Ineffective for Pediatric Otitis Media With Effusion

Short-Course Oral Steroids Ineffective for Pediatric Otitis Media With Effusion

By

A short course of oral steroids was not found to significantly improve otitis media with effusion in children.

Olaparib Treatment May Improve Health-Related Quality of Life in Germline <I>BRCA1/2</I>-Mutated Ovarian Cancer

Olaparib Treatment May Improve Health-Related Quality of Life in Germline BRCA1/2-Mutated Ovarian Cancer

By

Olaparib, may help to improve duration of good quality of life and quality-adjusted progression-free survival in germline BRCA1/2-mutated ovarian cancer.

More Articles by Rita Aghjayan

Sign Up for Free e-newsletters